apples and semaglutide Clinical trial in Ireland challenges beliefs about Ozempic similar new obesity treatments Semaglutide - Prime

doi:10.1126/scitranslmed.aay8071 37

The percentage of subjects with one deficit increased from 18 subjects (69.2%) to 19 subjects (73.1%) after 10 weeks, while the percentage of subjects with two deficits decreased from ten subjects (30.8%) to four subjects (15.4%) after 10 weeks intervention

for example, the translocation of Stenotrophomonas pavanii and Methylobacterium extorquens into peripheral blood increases the risk for HE.17 Sarcopenia is an important complication in cirrhosis and develops in nearly 5070% of cirrhotics;19 it also increases the risk for HE in those patients.20 Dasarathy et al

It can look different depending on whether you're taking the drug for weight loss or diabetes and why you want to come off it in the first place

Conversely, active metabolic disease (diabetes, severe hypertension), unstable weight patterns, or weak self-management capacity may warrant longer treatment or modified timelines